Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine

From the press release:
"The initial focus is Triple Negative Breast Cancer"

https://www.prnewswire.com/news-releases/anix...96402.html